NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.04
(5.71%)
AUD 0.04
(5.71%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 85.68 Thousand AUD | -85.66% |
| 2023 | 597.36 Thousand AUD | -73.06% |
| 2022 | 2.21 Million AUD | 892.65% |
| 2021 | 223.41 Thousand AUD | 152.35% |
| 2020 | 88.53 Thousand AUD | 41.7% |
| 2019 | 62.47 Thousand AUD | -18.21% |
| 2018 | 76.38 Thousand AUD | 77.02% |
| 2017 | 43.15 Thousand AUD | -64.66% |
| 2016 | 122.11 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 85.68 Thousand AUD | 0.0% |
| 2024 Q2 | 118.02 Thousand AUD | 0.0% |
| 2024 FY | 85.68 Thousand AUD | -85.66% |
| 2023 Q4 | 597.36 Thousand AUD | 0.0% |
| 2023 Q2 | 1.09 Million AUD | 0.0% |
| 2023 FY | 597.36 Thousand AUD | -73.06% |
| 2022 Q2 | 218.39 Thousand AUD | 0.0% |
| 2022 FY | 2.21 Million AUD | 892.65% |
| 2022 Q4 | 2.21 Million AUD | 0.0% |
| 2021 FY | 223.41 Thousand AUD | 152.35% |
| 2021 Q2 | 207.51 Thousand AUD | 0.0% |
| 2021 Q4 | 223.41 Thousand AUD | 0.0% |
| 2020 Q2 | 104.1 Thousand AUD | 0.0% |
| 2020 Q4 | 88.53 Thousand AUD | 0.0% |
| 2020 FY | 88.53 Thousand AUD | 41.7% |
| 2019 FY | 62.47 Thousand AUD | -18.21% |
| 2019 Q2 | 28.08 Thousand AUD | 0.0% |
| 2019 Q4 | 62.47 Thousand AUD | 0.0% |
| 2018 FY | 76.38 Thousand AUD | 77.02% |
| 2018 Q4 | 76.38 Thousand AUD | 0.0% |
| 2018 Q2 | 284.16 Thousand AUD | 0.0% |
| 2017 Q4 | 43.15 Thousand AUD | 0.0% |
| 2017 FY | 43.15 Thousand AUD | -64.66% |
| 2016 FY | 122.11 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 97.974% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | 72.076% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 99.084% |
| Biome Australia Limited | 5.37 Million AUD | 98.405% |
| Patrys Limited | 691.36 Thousand AUD | 87.607% |
| Orthocell Limited | 22.08 Million AUD | 99.612% |
| Imugene Limited | 33.14 Million AUD | 99.741% |
| Noxopharm Limited | 1.28 Million AUD | 93.351% |
| PYC Therapeutics Limited | 10.18 Million AUD | 99.159% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 99.331% |
| Prescient Therapeutics Limited | 2.32 Million AUD | 96.316% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | 94.73% |
| Cynata Therapeutics Limited | 1.17 Million AUD | 92.683% |
| CSL Limited | 27.88 Billion AUD | 100.0% |
| Arovella Therapeutics Limited | 2.05 Million AUD | 95.834% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | 76.745% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 99.695% |
| Starpharma Holdings Limited | 8.69 Million AUD | 99.015% |
| Nanollose Limited | 465.64 Thousand AUD | 81.599% |
| Memphasys Limited | 5.59 Million AUD | 98.468% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | 80.149% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 97.5% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 97.704% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | 91.806% |
| Race Oncology Limited | 1.91 Million AUD | 95.529% |
| Nyrada Inc. | 855.63 Thousand AUD | 89.986% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.966% |
| Dimerix Limited | 13.89 Million AUD | 99.383% |
| PharmAust Limited | 896.6 Thousand AUD | 90.444% |
| Immutep Limited | 10.97 Million AUD | 99.22% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 98.972% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 98.421% |
| BTC Health Limited | 203.94 Thousand AUD | 57.988% |
| Acrux Limited | 5.68 Million AUD | 98.493% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 99.8% |
| Biotron Limited | 737.5 Thousand AUD | 88.382% |
| Tissue Repair Ltd | 1.35 Million AUD | 93.657% |
| AdAlta Limited | 3.54 Million AUD | 97.581% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 99.808% |
| Hexima Limited | 248.67 Thousand AUD | 65.543% |
| AnteoTech Limited | 4.07 Million AUD | 97.897% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 97.61% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 99.461% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | 90.9% |
| Actinogen Medical Limited | 1.61 Million AUD | 94.696% |
| Immuron Limited | 2.84 Million AUD | 96.984% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 96.469% |